99 related articles for article (PubMed ID: 15666960)
1. Quetiapine in the successful treatment of psychosis and comorbid brittle diabetes mellitus: a case report.
Balter J; Mofsen R; Pinninti N
Int J Psychiatry Med; 2004; 34(3):259-66. PubMed ID: 15666960
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine in the elderly with parkinsonism and psychosis.
Wijnen HH; van der Heijden FM; van Schendel FM; Tuinier S; Verhoeven WM
Eur Psychiatry; 2003 Nov; 18(7):372-3. PubMed ID: 14643568
[TBL] [Abstract][Full Text] [Related]
3. Treating psychosis in Parkinson's disease with atypical antipsychotics.
Duggal HS; Singh I
Eur Psychiatry; 2005 Jan; 20(1):83-4. PubMed ID: 15642454
[No Abstract] [Full Text] [Related]
4. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
5. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
[TBL] [Abstract][Full Text] [Related]
6. Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in patients with schizoaffective disorder or schizophrenia: a randomized, open-label, parallel-group, flexible-dose study.
Di Fiorino M; Montagnani G; Trespi G; Kasper S
Int Clin Psychopharmacol; 2014 May; 29(3):166-76. PubMed ID: 24681810
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
Honer WG; MacEwan GW; Gendron A; Stip E; Labelle A; Williams R; Eriksson H;
J Clin Psychiatry; 2012 Jan; 73(1):13-20. PubMed ID: 21733490
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder.
Post DE
Behav Med; 2007; 33(1):11-4. PubMed ID: 17517541
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
McEvoy JP; Lieberman JA; Perkins DO; Hamer RM; Gu H; Lazarus A; Sweitzer D; Olexy C; Weiden P; Strakowski SD
Am J Psychiatry; 2007 Jul; 164(7):1050-60. PubMed ID: 17606657
[TBL] [Abstract][Full Text] [Related]
10. Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia.
Bushe C; Sniadecki J; Bradley AJ; Poole Hoffmann V
J Psychopharmacol; 2010 Jul; 24(7):1001-9. PubMed ID: 19240085
[TBL] [Abstract][Full Text] [Related]
11. Did CATIE influence antipsychotic use?
Citrome L; Jaffe A; Martello D; Allingham B; Levine J
Psychiatr Serv; 2008 May; 59(5):476. PubMed ID: 18451000
[No Abstract] [Full Text] [Related]
12. Quetiapine in the management of psychosis secondary to huntington's disease: a case report.
Seitz DP; Millson RC
Can J Psychiatry; 2004 Jun; 49(6):413. PubMed ID: 15283541
[No Abstract] [Full Text] [Related]
13. Tardive dyskinesia with quetiapine.
Ghelber D; Belmaker RH
Am J Psychiatry; 1999 May; 156(5):796-7. PubMed ID: 10327920
[No Abstract] [Full Text] [Related]
14. A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study.
Chengappa KN; Parepally H; Brar JS; Mullen J; Shilling A; Goldstein JM
Can J Psychiatry; 2003 Apr; 48(3):187-94. PubMed ID: 12728743
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine treatment in early psychosis: no evidence of cataracts.
Whitehorn D; Gallant J; Woodley H; Rui Q; Milliken H; Kopala L
Schizophr Res; 2004 Dec; 71(2-3):511-2. PubMed ID: 15474924
[No Abstract] [Full Text] [Related]
16. Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial.
Laties AM; Flach AJ; Baldycheva I; Rak I; Earley W; Pathak S
J Psychopharmacol; 2015 Jan; 29(1):69-79. PubMed ID: 25315830
[TBL] [Abstract][Full Text] [Related]
17. Long-term remission of schizophrenia in an adolescent treated with quetiapine.
Hayden F
J Child Adolesc Psychopharmacol; 2001; 11(3):289-93. PubMed ID: 11642479
[TBL] [Abstract][Full Text] [Related]
18. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ
Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951
[TBL] [Abstract][Full Text] [Related]
19. [Successful quetiapine therapy in psychotic patients with mood elevation].
Kecskés I
Neuropsychopharmacol Hung; 2009 Dec; 11(4):259-63. PubMed ID: 20150663
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of quetiapine in the management of psychotic depression in an adolescent boy with bipolar disorder, mixed, with psychosis.
Catapano-Friedman L
J Child Adolesc Psychopharmacol; 2001; 11(2):205-6. PubMed ID: 11436963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
